Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2007

PHARMANIAGA BERHAD

Financial Year End

31/12/2007
Quarter3
Quarterly report for the financial period ended30/09/2007
The figureshave not been audited

Attachments

3Q2007.pdf
101 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2007
30/09/2006
30/09/2007
30/09/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
334,700
289,040
891,166
790,927
2Profit/(loss) before tax
31,915
10,675
54,326
27,852
3Profit/(loss) for the period
21,561
5,396
35,271
17,209
4Profit/(loss) attributable to ordinary equity holders of the parent
21,302
5,039
34,011
15,974
5Basic earnings/(loss) per share (sen)
19.92
4.71
31.80
14.93
6Proposed/Declared dividend per share (sen)
0.00
0.00
15.00
11.50
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.1400
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
A final tax exempt dividend of 15.0% (2006 : 11.5%) on 106,963,188 (2006 : 106,958,888) ordinary shares of RM1.00 each in respect of the previous financial year amounting to RM16,044,478 (2006 : RM12,300,272) was paid on 13 July 2007.

The Directors do not recommend any payment of interim dividend for the current financial period ended 30 September 2007 (2006 : nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced22 Nov 2007  
CategoryFinancial Results
Reference NoPB-071120-34547